Back to SYRE

Affinity Asset Advisors, LLC → SYRE

Affinity Asset Advisors, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$113.9M
Q3 2026
Peak value
$113.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$46.9M
Q1 2026$64.5M
Q2 2026$113.6M
Q3 2026$113.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$113.9M1.28M——
Q2 2026$113.6M1.28M——
Q1 2026$64.5M1.28M——
Q4 2025$46.9M1.43M——

Other funds holding SYRE

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M
EQR

ERASCA INC

$96.2M
APGE

APOGEE THERAPEUTICS INC

$93.2M